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Abstract: The nitrogenase enzyme catalyzes the reduction of dinitrogen to ammonia and is composed 
of the Fe and MoFe proteins. The iron molybdenum cofactor (FeMo-co) of the MoFe protein is the site 
of active substrate reduction. The NifX protein has also been suggested to have a role in the FeMo-co 
synthesis, although its exact role is still open to investigation. We attempted to understand the role of 
NifX by determining the specific interactions it may have with other Nif proteins involved in FeMo-co 
synthesis, such as NifD, NifK, NifN, NifDK and NifH. Using the BacterioMatch Two-Hybrid System, 
a translationally fused construct of NifX with the N-terminal α-RNAP of the pTRG target vector was 
made and its interaction was tested with the NifDK fusion protein, translationally fused to the λCI of 
the pBT vector. The strength of the interaction, as determined by measuring the β-galactosidase 
activity, demonstrated that direct protein-protein interaction exists between NifDK and NifX proteins; 
the extent of interaction between NifK and NifX proteins was much higher than between NifD and 
NifX, when individually tested; also, reduced interaction was found between NifH and NifX.  
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INTRODUCTION 
 
  The nitrogenase enzyme converts the atmospheric 
nitrogen into a bioavailable form, thus serving as a 
focal point in structural, molecular and biochemical 
studies
[1-3]. The molybdenum containing nitrogenases 
(Mo-nitrogenases) are the best characterized 
metalloenzymes and are composed of two oxygen 
sensitive metalloproteins known as the MoFe protein 
(NifDK) and the Fe protein (NifH). The MoFe protein 
contains two types of metal centers, the P-cluster and 
the iron-molybdenum cofactor (FeMoco)
[4]. The 
FeMoco is the active site of the Mo-nitrogenase and 
composed of seven Fe, nine S, one Mo, one homocitrate 
and one
  atom of unidentified nature
[5,6]. It is entirely 
situated in the NifD subunit which provides one Cys 
and one His ligand for bonding with the Fe and Mo 
ends of its metallostructure respectively. Considerable 
research efforts have been directed towards 
understanding the biosynthesis and sequential assembly 
of the FeMoco and it is known that various nitrogen 
fixation (nif) genes play a role in the biosynthesis, 
assembly, transport and insertion of the FeMo-
cofactor
[7,8]. The products of the nifB, nifV, nifQ, nifH, 
nifE, nifN, nifX and nafY genes have been identified to 
be the prime players in these processes
[9-11].  
  Two different pathways for the biosynthesis of 
FeMoco could be pictured: (i) the FeMoco units could 
be sequentially assembled on the apo-MoFe or (ii) the 
FeMoco could be separately synthesized and then 
inserted onto the apo-MoFe protein. However, as 
established by past experiments, the second pathway 
proved to be accurate, whereby mutations in either nifB, 
nifN or nifE,  that are involved in the biosynthesis of 
FeMoco, resulted in very low molybdenum 
accumulation and a molybdenum-free MoFe 
protein
[12,13]. Thus it was demonstrated that an active 
FeMoco could be synthesized in the absence of the 
MoFe protein and that the FeMoco could accumulate on 
a different protein, such as an intermediate in the 
normal FeMoco biosynthetic pathway
[13]. A significant 
progress in determining the protein components 
involved in the biosynthesis of the FeMoco ensued 
from the development of an in vitro assay for FeMoco 
biosynthesis
[14]. This assay utilized a mixture of extracts 
prepared from mutant strains that presumably had 
complementary defects in FeMoco biosynthesis, so as 
to attempt reconstitution of the MoFe protein activity. 
This application proved immensely useful in 
recognizing NifH, NifEN and NifV as some of the key 
players in the FeMoco biosynthetic pathway and helped 
in the purification of an apo-MoFe protein
[13-17]. As 
understood from research conducted thus far, a stepwise Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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overview of the events involved in the biosynthesis and 
assembly of the FeMoco includes: (i) the formation of 
an Fe/S core of the FeMoco (designated NifB-co) by 
NifB
[18,19] (ii) transfer of the NifB-co to the α2β2 
tetrameric scaffold NifEN protein
[20,21] (iii) maturation 
of the FeMoco and apo-MoFe protein by the combined 
action of the Fe protein and MgATP
[17,22,23] and further 
processing of the NifB-co on NifEN by an unknown 
mechanism, forming the completed FeMoco (iv) the 
final transfer of the fully formed FeMoco
  to a nafY-
encoded protein, called
 γwhich is a FeMoco carrier that 
aids in the insertion of the FeMoco into the apo-
MoFe
[24,25]. In addition to these major events, a few 
other important steps are also involved in the entire 
process.The NifU and NifS proteins participate in the 
initial Fe/S mobilization
[26,27], the NifQ protein is 
involved in an early stage of the metal core formation 
and found to be essential in Mo-limiting conditions
[28], 
the NifV protein contributes the homocitrate component 
of the FeMoco
[29] and the NifX protein probably 
functions as an 'escort' protein that delivers the FeMoco 
or its precursors from one assembly site to another or 
plays a role in specifying the organic acid moiety of 
FeMoco
[30,31].  
  Although a wealth of data is available to support 
the functions of the NifU, NifS, NifB, NifEN, NifH and 
NifV, more research is required to explain the role of 
the NifX protein. The nifX gene is located downstream 
of the nifEN genes, such that nifENX are transcribed as 
a single transcription unit. The NifX protein is 
comprised of 158 amino acids and is a ~17 kDa 
protein
[32]. The small molecule binding domain 
(SMBD) of NifX has widespread phyletic distribution 
and therefore indicates an ancient origin or extensive 
dissemination by horizontal transfer during evolution, 
or both
[33]. Eventhough a deletion in the nifX gene did 
not show a significant effect on the nitrogenase activity 
in vivo, the purified NifX protein was shown to be 
important in the stimulation of FeMoco synthesis in an 
in vitro FeMoco synthesis reaction
[10,34]. The NifX, 
NifB, NifY and NafY are most likely related proteins, 
owing to their overall sequence similarity and the 
presence of a FeMoco binding 'core domain' in all of 
them
[35]. This conserved family of proteins has a 
β1−β2−β3−α1−α2−β4−α3−β5−α4−α5  fold in its core 
domain, a polarized surface charge distribution and 
shows considerable
 similarity with the ribonuclease H 
family
[35]. In NifB, the NIFX SMBD is fused with a 
biotin-synthase-like, metal-dependent catalytic domain 
and in the archaeal MTH1172 protein, it is fused to a 
cation transporter
[33]. Previous studies in Azotobacter 
vinelandii have identified certain important molecular 
interactions of the NifX protein with the other Nif 
proteins involved in the FeMoco biosynthesis/transport 
pathway; mainly it was shown that NifX binds to the 
NifB-co and also a FeMoco precursor from the NifEN 
complex
[10,30].  
  Clearly, a protein-protein interaction based study of 
NifX with other FeMoco maturation proteins would 
enhance our insight into the role of NifX and may help 
to solve unanswered questions regarding its position in 
the FeMoco biosynthetic pathway. We therefore studied 
the interactions of NifX with some of the other relevant 
proteins participating in FeMoco biosynthesis 
/assembly/transport /insertion, so as to deduce the entire 
sequence of events involved. We determined the 
specific interactions of NifX with NifB, NifH, NifN, 
NifD, NifK, NifDK (fusion) and NafY using the 
BacterioMatch Two-Hybrid System
TM[36,37]. 
Accordingly, a translationally fused construct of NifX 
with the N-terminal α-RNAP of the pTRG target vector 
was made and its interaction was tested with the above 
proteins, each translationally fused to the λCI of the 
pBT vector. The strength of the interactions, as 
determined by measuring the β-galactosidase activity, 
demonstrated that direct protein-protein interaction 
exists between (i) NifB and NifX (ii) NafY and NifX 
and (iii) NifDK (fusion) and NifX (iv) NifK and NifX. 
The extent of interaction between NifK and NifX 
proteins was much higher than between NifD and NifX, 
when individually tested; also, unsubstantial interaction 
was found between NifH and NifX and NifN and NifX. 
Our results present a new dimension to the FeMoco 
biosynthesis pathway with reference to the role played 
by NifX. We propose that the NifX performs 
overlapping functions in the FeMoco biosynthetic 
pathway wherein it may either function as a transporter 
of the FeMoco precursor to the NafY protein or directly 
assist in the insertion of the completed FeMoco into the 
apo-MoFe protein. 
 
MATERIALS AND METHODS 
 
Strains, plasmids and growth conditions: The 
bacterial strains and plasmids used in this study are 
described in Table 1. E. coli strains were normally 
grown at 37°C in 2YT media
[38]. Ampicillin, 
chloramphenicol and tetracycline were used to a final 
concentration of 50, 34 and 5 µg mL¯
1, respectively, 
wherever the selection was made. 
 
General molecular techniques: Restriction enzymes 
were purchased from Promega (Madison, WI). DNA 
sub-cloning, plasmid DNA isolations, restriction  Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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Table 1:  Bacterial Strains and Plasmids used in this study 
Strain/plasmid Relevant  characteristics and description  Source/reference 
Escherichia coli 
TOP10 
F
-mcrA ∆ (mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(araleu)7697 
galU galK rpsL (Str
R) endA1 nupG 
Invitrogen, CA 
Escherichia coli XL-1 
Blue 
MRF’ K, ∆(mcrA) 183∆(mcr CB-hsdSMR-mrr) 173  endA1 supE44 thi-1 recA1 gyrA96 relAl 
lac (F’ pro AB lacI
q Z ∆ M15 Tn5 (Kan)
r] 
Stratagene, CA 
PCR 2.1 TOPO  Amp
r, Kan
r, (3.9kb), used for direct cloning of  PCR products, lacZα fragment, MCS, M13 Invitrogen,  CA 
pBT  Cm
R, 52 bp MCS, 3.2 kb size, MCS, p15A origin of replication, lac-UV5 , λ cl ORF  Stratagene, CA 
pTRG  Tet
R, 60 bp MCS, 4.4 kb size, MCS, lac-UV5 promoter, CoE1 origin of replication, RNAPα 
ORF 
Stratagene, CA 
pBG1866  Derivative of pBT in which 879 bp nifH fragment was cloned into BamHI site of pBT to 
generate an in-frame λCI:NifH translation fusion 
[39] 
pBG1713  Derivative of pBT in which 3062 bp orf corresponding to nifD-K fusion gene from XhoI-
EcoRV digested pBG1712 was cloned into SmaI-XhoI site of pBT bait vector to generate an 
in-frame λCI:NifD-K translation fusion 
[40] 
pBG1716  Derivative of pTRG in which 2335 bp nifKTY fragment was cloned into the BamHI site of 
pTRG to generate an in-frame α-RNAP: NifX translation fusion 
[40] 
pBG1718  Derivative of pBT in which 2335 bp nifKTY fragment released from BamHI digested 
pBG1715 was cloned into BamHI site of pBT to generate an in-frame λCI NifKTY 
translation fusion 
[40] 
pBG1777  Derivative of PCR 2.1 TOPO in which 1377 bp nifN fragment was cloned directly after PCR 
using appropriate olignonucleotides designed with flanking EcoRI-BamHI sites 
This study 
pBG1778  Derivative of pBT in which 1377 bp nifN fragment released from EcoRI-BamHI digested 
pBG1777 was cloned into the EcoRI-BamHI site of pBT to generate an in-frame λCI:NifN 
translation fusion 
This study 
pMH5014  Derivative of PCR 2.1 TOPO in which 1-300 bp nifX fragment was cloned directly after 
PCR using appropriate olignonucleotides designed with flanking BamHI-EcoRI sites 
This study 
pBG1786  Derivative of pTRG in which 1-300 bp nifX fragment released from BamHI-EcoRI digested 
pMH5014 was cloned into the BamHI-EcoRI site of pTRG to generate an in-frame α-
RNAP:N1NifX translation fusion 
This study 
pBG1782  Derivative of PCR 2.1 TOPO in which 150-477 bp nifX fragment was cloned directly after 
PCR using appropriate olignonucleotides designed with flanking BamHI-EcoRI sites 
This study 
pBG1787  Derivative of pTRG in which 150-477 bp nifX fragment released from BamHI-EcoRI 
digested pBG1782 was cloned into the BamHI-EcoRI site of pTRG to generate an in-frame 
α-RNAP:C2NifX translation fusion 
This study 
pMH5000  Derivative of PCR 2.1 TOPO in which 477 bp nifX fragment was cloned directly after PCR 
using appropriate olignonucleotides designed with flanking BamHI-EcoRI sites 
This study 
pMH5002  Derivative of pTRG in which 477 bp nifX fragment released from BamHI-EcoRI digested 
pMH5000 was cloned into the BamHI-EcoRI site of pTRG to generate an in-frame α-
RNAP:NifX translation fusion 
This study 
pMH6000  Derivative of PCR 2.1 TOPO in which 1509 bp nifB fragment was cloned directly after PCR 
using appropriate olignonucleotides designed with flanking EcoRI-BamHI sites 
This study 
pMH6002  Derivative of pBT in which 1509 bp nifB fragment released from EcoRI-BamHI digested 
pMH6000 was cloned into the EcoRI-BamHI site of pBT to generate an in-frame λCI:NifB 
translation fusion 
This study 
pBG1785  Derivative of PCR 2.1 TOPO in which 732 bp nafY fragment was cloned directly after PCR 
using appropriate olignonucleotides designed with flanking EcoRI-BamHI sites 
This study 
pBG1790  Derivative of pBT in which 732 bp nafY fragment released from EcoRI-BamHI digested 
pBG1785 was cloned into the EcoRI-BamHI site of pBT to generate an in-frame λCI:NafY 
translation fusion 
This study 
 
enzyme digestions, agarose gel electrophoresis, 
ligations and E. coli transformation were carried out as 
described in the laboratory manual or according to the 
manufacturer’s protocol
[37,38]. Oligonucleotides used for 
PCR amplification were purchased from Integrated 
DNA Technologies (Coralville, IA). Following are the 
primers used to PCR amplify required gene fragments 
from A. vinelandii cells for cloning into pTRG or pBT 
vectors of the BacterioMatch Two Hybrid System
TM: 
(1)  nifX  (pTRG) (i) 5’ GGA TCC ATG TCC AGC 
CCG ACC GGC 3’. (2) nifB (pBT) (i) 5’ GAA TTC 
AGA ACT GAG CGT ACT TGG GCA AAA CAA T 
3’ and (ii) 5’GGA TCC TCA GGC CTT GGC CTG 
CAG CAG GGC T 3’ (3) nifN (pBT) (i) 5’GAA TTC 
ATG GCC GAG ATC ATC AAT CGC AAC AAG 
GCC 3’ and (ii) 5’ GGA TCC TCA GTG CCT CCA 
TTG CGG CTG TTC GGT TGC CGG 3’ (4) nafY 
(pBT) (i) 5’GAA TTC AGT AAC CCC CGT GAA Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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CAT GAG TCG CGA 3’ (ii) 5’ GGA TCC TCA TGC 
CCT GGC CGC CTC GTC CTC GTC 3’ (5) First 300 
bp of nifX  encoding N-terminal NifX (pTRG) (i) 5’ 
GGA TCC ATG TCC AGC CCG ACC CGA CAA 
TTG CAG GTA 3’ (ii) 5’ GAA TCC GGC CAT CAA 
CTG GCG CAC CGC CGA GGC GCC 3’ (6) Last 324 
bp of nifX encoding C-terminal NifX (pTRG) (i) 
5’GGA TCC CGC TCC CAG CTC CTC TCG GTC 
GTC GAG TTC 3’ (ii) GAA TTC CTA TTC GTC 
CCA GCC TTC GGC GGC CAT GGC 3’. In all the 
above oligonucleotides, the underlined sequences 
represent restriction enzyme recognition sites that were 
introduced during primer design so as to facilitate 
cloning of the DNA fragments into unique sites of the 
pBT or pTRG vectors. 'GGA TCC' is the BamHI 
recognition sequence and 'GAA TTC' is the EcoRI 
recognition sequence. The bacterial two-hybrid vectors 
pBT bait and pTRG target, containing the λCI and α-
RNAP domains, respectively, were the starting 
plasmids used for cloning the various gene fragments. 
Each gene fragment was PCR amplified using specific 
oligonucleotides as listed above and cloned into PCR 
2.1 TOPO (Invitrogen, Carlsbad, CA) by ligation and 
transformation. These plasmids were then digested with 
EcoRI and BamHI and the resulting fragments were 
purified and ligated to the EcoRI-BamHI digested pBT 
or pTRG vectors. The ligated mixtures were used to 
transform  E. coli XL1-Blue cells and desired clones 
were obtained and verified from the subsequent 
transformants by DNA isolation and restriction 
digestion analysis. The verified clones were designated 
as pMH5002 (α-RNAP + NifX),  pBG1786  (α-RNAP 
+N-terminal (N1) NifX), pBG1787 (α-RNAP +C-
terminal (C2) NifX), pMH6002 (λCI +  NifB), 
pBG1778 (λCI  + NifN) and pBG1790 (λCI +  NafY). 
The construction of the plasmids pBG1716 (α-RNAP + 
NifK), pBG1718 (λCI  + NifK) and pBG1866 (λCI + 
NifH) has been described elsewhere
[39,40]. Subsequently, 
desired combinations of plasmids (e.g. pTRG-NifX + 
pBT-NafY) were used for cotransformation of E. coli 
XL1-Blue cells containing the reporter cassette. The 
resultant cotransformants were inoculated for 
performing β-galactosidase activity assays. 
 
β-Galactosidase assay: The β-galactosidase activity 
assay was performed as described under ‘Molecular 
cloning’
[38]. Briefly, single E. coli transformants were 
inoculated into 5 mL of 2YT media supplemented with 
34 µg  mL¯
1 of chloramphenicol and 5  µg mL¯
1 of 
tetracycline. The cells were then incubated overnight at 
37  °C with shaking at 250  rpm. Then 200  µL of the 
overnight culture was diluted into 5 mL of the same 
media and incubated at 37 °C with shaking, until OD600 
was between 0.3 and 0.6 (initial OD600 was 0.05). Cells 
from 1.5 mL of the culture were collected by 
centrifugation and resuspended in 500 µL Z-buffer
[38]. 
The resuspended cells were lysed by adding 50 µL of 
chloroform and 25 µL of 0.1% SDS and kept at 28 °C 
with shaking for 5–10  min. To measure the β-
galactosidase activity from the cell lysate, 900 µL of Z-
buffer-β-mercaptoethanol solution (0.27 mL of β-
mercaptoethanol per 100 mL of Z-buffer) was added to 
100 µL culture followed by 200 µL Z-buffer/ONPG (o-
nitrophenyl-β-D-galactopyranoside—4 mg  ONPG  per 
mL of Z-buffer). The time of ONPG addition was 
recorded and the tubes were incubated at 37 °C. When 
yellow color was visible, 500 µL of 1 M Na2CO3 was 
added to each tube to terminate the reaction and the 
time was recorded. The optical densities at 420 nm as 
well as 550  nm were recorded. The β-galactosidase 
units were defined as the amount of enzyme which 
hydrolyzes 1  µmol of ONPG to o-nitrophenol and D-
galactose per minute. β-Galactosidase activity in Miller 
Units was calculated as 
1000 × [OD420 − (1.75 × OD550)/(t × V × OD600)], where 
t is the elapsed time (in min) of incubation, V is the 0.1 
mL × concentration factor and OD600 is the absorbance 
of 1 mL of culture at 600 nm. 
 
Structural homology modeling: The Swiss PDB 
software (freely available online)
[41] was used for 
homology modeling and 3D representation of the 
derived NifX protein structure. The NafY structure 
(PDB ID: 1P90) was used as the template for 
superimposing the raw NifX amino acid sequence and 
deriving its 3D structure. 
 
RESULTS AND DISCUSSION 
 
  Interaction of NifB with NifX.  The 
BacterioMatch
TM Two-Hybrid System was used to 
determine which proteins in the FeMoco maturation 
pathway directly interacted with NifX. The NifB 
protein provides a Fe-S precursor, termed
 NifB-co, for 
FeMoco assembly
[18,19]. Since the nifB gene product 
was found to be essential for the functioning of 
alternative nitrogenases (Mo-independent) also, 
therefore it is thought that the NifB-co represents the 
Fe-S primary cluster for both, the synthesis of FeMoco 
and the cofactors of alternative nitrogenases
[18,42]. It is 
believed that the NifB-co is transferred from
 NifB to 
NifEN, which acts as a site for rearrangement of the 
primary [Fe-S] to form the [Fe-S] core of the FeMoco, 
probably after a structural contact between NifEN and Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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NifH
[19]. The NifB protein sequence comprises of two 
different domains: an N-terminal SAM radical domain 
and a C-terminal NifX-like domain, that is a domain 
present in certain FeMoco binding proteins
[43]. The 
presence of the C-terminal NifX-like domain could 
indicate that this region in NifB is either involved in 
binding NifB-co precursors and forming the NifB-co or 
binding a preformed NifB-co for transfer to another 
protein in the FeMoco biosynthetic pathway
[44].  
  Although it was evident from previous reports that 
NifX is capable of binding to NifB-co in one of the 
stages during FeMoco biosynthesis
[30], a direct protein-
protein interaction between the NifB and NifX proteins 
had not been demonstrated before. Our results support 
the idea that there is an interaction between NifB and 
NifX as found by measuring the β-galactosidase 
activity of E. coli cotransformants harboring the 
plasmids pMH6002 (λCI:NifB) and pMH5002 
(RNAP:NifX). As compared to the β-galactosidase 
activity obtained from E. coli cotransformants 
harboring only the pBT and pTRG plasmids (negative 
control--22.93 + 6.12 Miller Units), the activity 
obtained from cells harboring pMH6002 and pMH5002 
was much higher (49.7 + 9.11 Miller Units), indicating 
a protein-protein interaction between NifB and NifX 
(Table 2). Since the NifB and NafY proteins share 
many similarities between their amino acid sequences 
and since NafY was shown to bind to the 
apodinitrogenase
[35], we also examined the ability of 
NifB and NifK to interact with each other and found 
that the β-galactosidase activity of E. coli 
cotransformants harboring the plasmids pMH6002 
(λCI:NifB) and pBG1716 (RNAP:NifK) was 20.47 + 
4.78 Miller Units, suggesting lack of interaction 
between NifB and NifK. 
 
Interaction of NafY with NifX: A new family of iron 
and molybdenum (or vanadium) cluster-binding 
proteins comprising of NifY, NifX, VnfX and NafY 
was described by Rubio et. al in 2002
[25]. The A. 
vinelandii NafY protein (nitrogenase accessory factor 
Y, also known as γ, was reported to be a molecular 
chaperone that assisted in maintaining the 
apodinitrogenase in a conformation that facilitated the 
insertion of the FeMoco by acting as a metallo-
insertase
[25]. Mutational analysis of the strains 
containing mutations in both nafY and nifX showed that 
these were severely affected in diazotrophic growth, 
indicating their physiological importance in the 
stabilization of the apodinitrogenase
[25]. Subsequently, 
the 3-dimensional structure of the NafY protein from A. 
vinelandii revealed two distinct domains of this protein: 
an N-terminal (Met1 to Leu98) domain and a C-
terminal (Glu99 to Ser232) 'core' domain
[35]. The NafY 
core domain was shown to be capable of binding the 
FeMoco of nitrogenase but unable to bind to 
apodinitrogenase in the absence of the N-terminal 
domain
[35].  
  In a study that involved utilization of 
99Mo and a 
purified  in vitro FeMo-co biosynthesis system for 
investigating the incorporation of the 
99Mo radiolabel 
into proteins involved in the biosynthesis of FeMo-co, 
it was found that there was transfer of the 
99Mo label 
from NifH and NifX to NafY or apodinitrogenase
[31]. In 
light of the earlier experiments, our data strengthens the 
role of NifX as a transporter of a fully formed FeMoco 
cluster to NafY. Our work helped in detecting a direct 
protein-protein interaction between NifX and NafY, as 
evident from the β-galactosidase activity (42.49 + 8.62 
Miller Units) of E. coli cells harboring the plasmids 
pMH5002 (RNAP:NifX) and pBG1790 (λCI:NafY) 
(Table 2). Through earlier studies, it was predicted that 
the NifX was involved in the latter part of the 
biosynthetic pathway of FeMoco formation
[31]. Our 
results confirmed the above prediction, because we 
were able to identify an interaction between NifX with 
NafY but neither between NifX and NifN or NifX and 
NifH, both of which are involved in the initial steps of 
the pathway. The β-galactosidase activity 
corresponding to the interaction between NifH and 
NifX was 32.98 + 6.67 Miller Units and between NifN 
and NifX was 31.32 + 6.05 Miller Units, indicating 
absence of any interaction between these pairs of 
proteins, when compared to the negative and positive 
controls (22.93 + 6.12 and 115.59 + 25.01 Miller Units 
respectively) (Table 2). We also tested the validity of 
the results obtained through the BacterioMatch
TM Two 
Hybrid system by determining whether the NafY and 
NifK proteins, that have been reported to associate with 
each other based on immunoblot analyses in earlier 
studies
[35], showed evidence of interaction with each 
other by this method. Our results established that a 
strong interaction exists between the NafY and NifK 
proteins (55.71 + 9.30 Miller Units) and that this 
bacterial two-hybrid method was indeed reliable for our 
experimental objectives (Table 2). 
 
Interaction of NifDK (fusion) and NifK with NifX: A 
role for NifX in the insertion process of the FeMoco 
into apodinitrogenase has been suggested earlier
[31]. In 
that study, the in vitro FeMoco biosynthesis assay was 
performed and the incorporation of 
99Mo radiolabel into 
apodinitrogenase was examined in reactions including 
and excluding NifX. It was found that the minus NifX  Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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Table 2:  Results of the liquid β-galactosidase assay with ONPG as substrate to demonstrate protein-protein interaction 
Plasmid to which λCI was 
translationally fused 
Plasmid to which α-RNAP was 
translationally fused  
β-Galactosidase activity 
(Miller units)
a 
Interacting Peptides 
pBG1713 (λCI: NifD-K fusion)  pMH5002 (RNAP: NifX)  45.24 ± 8.72  NifD-K and Nif X 
pMH5007 (λCI: NifD)  pMH5002 (RNAP: NifX)  36.95 ± 3.74  None 
pBG1718 (λCI: NifK)  pMH5002 (RNAP: NifX)  46.34 ± 8.81  NifK and NifX 
pBG1718 (λCI: NifK)  pBG1786 (RNAP:N1NifX)  33.93 ± 8.74  None 
pBG1718 (λCI: NifK)  pBG1787 (RNAP:C2NifX)  35.50 ± 7.81  None 
pBG1778 (λCI: NifN)  pMH5002 (RNAP: NifX)  31.32 ± 6.05  None 
PBG1866 (λCI: NifH)  pMH5002 (RNAP: NifX)  32.98 ± 6.67  None 
pMH6002 (λCI: NifB)  pMH5002 (RNAP: NifX)  49.7 ± 9.11  NifB and NifX 
pMH6002 (λCI: NifB)  pBG1716  (RNAP: NifK)  20.47 ± 4.78  None 
pBG1790 (λCI: NafY)  pMH5002 (RNAP: NifX)  42.49 ± 8.62  NafY and NifX 
pBG1790 (λCI: NafY)  pBG1716 (RNAP: NifK)  55.71 ± 9.30  NafY and NifK 
pBT  pMH5002 (RNAP: NifX)  29.87 ± 1.63  None 
pBT  PTRG  22.93 ± 6.12  None 
pBT-LGF2 
 
pTRG-Gal11
p  115.59 ± 25.01  Mutant form of Gal1 protein 
with Gal11
P 
aEach assay was performed a minimum of four times for accuracy and the β-galactosidase activity units shown are an average of three 
independent observations. 
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Fig. 1:  Homology modeling of NifX using NafY core structure. The 
NafY core domain structure (PDB ID: 1P90) was used as a 
template for homology modeling of NifX.  The NafY 
structure is represented in ribbons and the NifX structure in 
backbone. The NafY core domain start (Glu99) and NifX 
start (Met 1) are indicated by arrows. The His121 ligand of 
NafY that is known to be important for FeMoco binding (11) 
is shown to coincide with the His35 residue of NifX 
 
reaction showed lower levels of 
99Mo label 
incorporated into dinitrogenase in comparison to the 
NifX containing reaction
[31]. Evidence obtained through 
our two-hybrid data clearly indicates the presence of 
protein-protein interaction between the NifDK protein 
encoding a single fused unit of dinitrogenase
[45] and 
NifX and between the NifK component of the 
dinitrogenase and NifX. To further analyze if the NifX 
protein possessed specific or separate domains that 
helped in its interaction with 300 bp of nifX, encoding 
the N-terminal half of the NifX protein (N1X) and the 
region spanning 216-477 bp of nifX, encoding the C-
terminal half of NifX fusion) and pMH5002 (α-
RNAP:NifX) was 45.24 ± 8.72 Miller Units and that of 
pBG1718 (λCI: NifK) and pMH5002 (α-RNAP:NifX) 
was 46.34 ± 8.81. The β-galactosidase activity of the 
positive control that included cotransformed plasmids 
encoding two known interacting proteins – a mutant 
form of Gal1 protein and the Gal11
P, fused to λCI of 
pBT and α-RNAP of pTRG respectively, was 115.59 + 
25.01 Miller Units and value for the negative control 
that included cotransformed plasmids pBT and pTRG 
only was 22.93 + 6.12 Miller Units. The β-
galactosidase activity corresponding to interaction 
between NifD and NifX was 36.95 ± 3.74 Miller Units, 
suggesting that there was much lesser or no interaction 
between the two proteins (Table 2). To further analyze 
if the NifX protein possessed specific or separate 
domains that helped in its interaction with 300 bp of 
nifX, encoding the N-terminal half of the NifX protein 
(N1X) and the region spanning 216-477 bp of nifX, 
encoding the C-terminal half of NifX the NifK protein, 
we cloned the region spanning 1-300 bp of nifX, 
encoding the N-terminal half of the NifX protein (N1X) 
and the region spanning 216-477 bp of nifX, encoding 
the C-terminal half of NifX (C2X), into the pTRG 
plasmid. The β-galactosidase activity indicating the 
extent of interaction between NifK and NifN1X was 
33.93  ± 8.74 Miller Units and between NifK and 
NifC2X was 35.50 ± 7.81 Miller Units (Table 2). Thus, 
the N-terminal and C-terminal NifX domains were 
unable to retain the ability to interact with the NifK 
protein individually, indicating that either the entire 
NifX protein is essential for interaction with NifK or a 
domain comprising an overlapping region from the N- Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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Fig. 2:  ClustalW alignment of NifX and NafY protein sequences from A. vinelandii 
 
terminal and C-terminal domains contains the necessary 
stretch of residues for interacting with NifK.  
  The NifX family of proteins comprises of proteins 
like NifB, NifY, NafY, VnfX and NifX and is based on 
the presence of a FeMoco-cluster binding domain. As 
seen in Fig. 1., the NifX protein is largely similar to the 
C-terminal domain of the NafY protein. The C-terminal 
NafY protein known as the ‘core’ domain, was shown 
to be capable of binding to the FeMoco but unable to 
bind to the apodinitrogenase in the absence of the first 
domain, indicating that the N-terminal region of NafY 
was important in interacting with dinitrogenase
[35]. Our 
studies have demonstrated that the NifX is capable of 
interacting with the NifK protein. The fact that the NifX 
does not have a domain corresponding to the N-
terminal region of NafY and yet is able to interact with 
NifK could be explained as a possible conservation of a 
few residues at the beginning of the NifX protein that 
are important in maintaining an interaction with NifK 
(Fig. 2). It could also be that whereas NafY interacts 
with a different region of the dinitrogenase protein, the 
NifX acts upon yet another separate region of the same 
protein and therefore the NifX protein which could 
actually be considered as only the C-terminal half of 
NafY, may be involved in the dual role of FeMoco 
binding and dinitrogenase binding but awaits specific 
evidence regarding the residues involved.  
  Through this work, utilizing a simple two-hybrid 
approach, we have been able to reveal certain important 
interactions between the NifX protein and some other 
proteins related to the FeMoco biosynthetic pathway of 
nitrogenase. Mainly, the following interactions were 
found: (i) NifB and NifX (ii) NafY and NifX (iii) 
NifDK(fusion) and NifX (iv) NifK and NifX. Further 
protein-protein interaction based studies involving 
NifU, NifS, NifQ and NifV with NifX would certainly 
prove useful in better deciphering the role of NifX and 
the events of the FeMoco biosynthetic pathway as a 
whole. However, in light of our current findings and 
several previous insights into the FeMoco biosynthetic 
pathway, we propose a model that best explains the 
order of events that occurs during the FeMoco 
biosynthesis, assembly and insertion. It should be noted 
that there exist several different views of the exact Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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NifUS
Fe-S
NifB NifB co
NifEN NifX
?
NifH
Homocitrate, 
Mo
NifX NafY
GroEL
FeS processing -
FeMoco insertion/
stabilization 
NifDK
α
α β
β
ΕΝ
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Fig. 3:  Proposed model for the role of NifX in FeMoco biosynthesis/insertion pathway. The NifU and NifS proteins participate in the initial Fe/S 
mobilization; this precursor Fe-S moiety is then transferred to the NifB protein, which is then termed as NifB-co. The NifX protein may 
play a role as a molybdenum (Mo) carrier from the NifB to the NifEN complex or it may provide the homocitrate moiety to NifEN. This 
processed FeMoco is inserted and stabilized in the NifDK (MoFe) protein and this activity is assisted by NifX, NafY and GroEL 
 
sequence of events in the FeMoco biosynthetic pathway 
due to the complexity of the system and possible 
redundant functions of the involved proteins, causing 
difficulty in assigning confirmed roles. As seen in our 
suggested model in Fig. 3, the FeMoco biosynthetic 
pathway starts with the initial mobilization and 
assembly of the Fe-S fragments and is carried out by 
the NifUS complex
[26]; This Fe-S fragment is then 
delivered to NifB and a Fe-S core is formed on it
[18]. 
Following this, the core is transferred from NifB to the 
NifEN complex. Based on previous studies and the 
detection of an interaction between NifB and NifX in 
our study, it could be possible that NifX facilitates the 
transfer of the core from NifB to NifEN
[30]. It is 
possible that the addition of homocitrate takes place at 
this step, since one previous study has shown that the 
NifX may be involved in specifying the organic acid 
moiety of the FeMoco precursor
[31]. Following this, 
multiple FeMoco processing steps take place on the 
NifEN complex, which acts as a scaffold for this 
purpose
[7,8]. Very recently, Corbett et. al showed 
through x-ray absorption spectroscopy studies that the 
first isolatable FeMoco precursor on NifEN was a 
molybdenum-free analog of FeMoco and that the 
molybdenum was probably incorporated afterwards at 
the position previously occupied by the non-cysteine 
ligated terminal iron atom
[46]. As found in other recent 
studies, the NifH may perform the role of facilitating 
the insertion of Mo and homocitrate into the FeMoco, 
probably after MgATP hydrolysis
[47]. The GroEL Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
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protein is also required for the final assembly of the 
MoFe protein; It functions as a molecular chaperone for 
insertion of FeMoco into the MoFe protein
[48]. It could 
be possible that the MgATP hydrolysis is actually 
necessary for the function of GroEL in the final 
assembly reaction and has no significant link with the 
NifH protein
[48]. As found in our studies, the interaction 
of NifX with NafY indicates that the NifX may again 
function as an escort protein at this step and participate 
in the transfer of the intermediate or completed FeMoco 
cluster to the NafY protein. In the following steps, the 
assembled FeMoco that has been delivered to the NafY 
protein is carried to the apo-dinitrogenase. It has been 
suggested that the NafY protein dissociates from the 
MoFe protein after the final insertion process in 
completed. Since we have detected an interaction 
between the NifX and NifK proteins in this work, we 
propose that the NifX may perform a similar role to that 
of NafY and the final insertion of the FeMoco into the 
apo-dinitrogenase may involve the participation of 
NifX. It may also be possible that the NifX stabilizes 
the apo-dinitrogenase in a conformation suitable for 
FeMoco insertion through its interaction with NifK. 
There have been earlier speculations concerning the 
overlapping or redundant roles of the proteins involved 
in the FeMoco biosynthetic pathway, for example, the 
role of NifY was found to be similar to that of NafY in 
studies involving the FeMoco biosynthetic pathway in 
K. pneumoniae and A. vinelandii
[49]. However, this 
occurrence has not been yet explainable and future 
studies that investigate the FeMoco biosynthetic 
pathway in detail may lead to meaningful answers. 
 
ACKNOWLEDGMENTS 
 
  Part of this work was done at Bowling Green State 
University, Ohio. This research is partly supported by 
NIH and NSF to NG and LP. This material was also 
based on work supported by the National Science 
Foundation, while NG working at the Foundation. We 
thank members of Gavini/Pulakat laboratory for helpful 
discussions and technical help.  
 
REFERENCES 
 
1.  Barney, B.M., H.I. Lee, P.C. Dos Santos, B.M., 
Hoffman, D.R. Dean and S.C. Seefeldt, 2006. 
Breaking the N2  triple bond: insights into the 
nitrogenase mechanism. Dalton Trans., 19: 2277-
84. 
2.  Igarashi, R.Y. and L.C. Seefeldt, 2003. Nitrogen 
fixation: the mechanism of the Mo-dependent 
nitrogenase. Crit. Rev. Biochem. Mol. Biol., 38: 
351–384. 
3.  Rees, D.C., F.A. Tezcan, C.A. Haynes, M.Y. 
Walton, S. Andrade, O. Einsle and J.B. Howard, 
2005. Structural basis of biological nitrogen 
fixation. Philos. Trans. R. Soc. London A, 363: 
971–984. 
4.  Howard, J.B. and D.C. Rees. 1996. Structural basis 
of biological nitrogen fixation. Chem. Rev., 96: 
2965–2982.  
5.  Chan, M.K., J. Kim and D.C. Rees, 1993. The 
nitrogenase FeMo-cofactor and P-cluster pair: 2.2 
A resolution structures. Science, 260: 792–794. 
6.  Einsle, O., F.A. Tezcan, S.L. Andrade, B. Schmid, 
M. Yoshida, J.B. Howard and D.C. Rees, 2002. 
Nitrogenase MoFe-protein at 1.16 A resolution: A 
central ligand in the FeMo-cofactor. Science. 297: 
1696–1700. 
7.  Dos Santos, P.C., D.R. Dean, Y. Hu and M.W. 
Ribbe, 2004. Formation and insertion of the 
nitrogenase iron-molybdenum cofactor. Chem. 
Rev., 104: 1159–1174. 
8.  Rubio, L.M. and P.W. Ludden, 2005. Maturation 
of Nitrogenase: a Biochemical Puzzle. J. Bacteriol., 
187: 405–414.  
9.  Peters, J.W., K. Fisher and D.R. Dean, 1995. 
Nitrogenase structure and function: a biochemical-
genetic perspective. Annu. Rev. Microbiol., 49: 
335–366. 
10.  Shah, V.K., P. Rangaraj, R. Chatterjee, R.M. Allen, 
J.T. Roll, G.P. Roberts and P.W. Ludden, 1999. 
Requirement of NifX and other Nif proteins for in 
vitro biosynthesis of the iron-molybdenum cofactor 
of nitrogenase. J. Bacteriol., 181: 2797–2801. 
11.  Rubio, L.M., S.W. Singer and P.W. Ludden. 2004. 
Purification and characterization of NafY 
(apodinitrogenase {gamma} subunit) from 
Azotobacter vinelandii. J. Biol. Chem., 279: 19739-
19746. 
12.  Imperial, J., V.K. Shah, R.A. Ugalde, P.W. Ludden 
and W.J. Brill, 1987. Iron-molybdenum cofactor 
synthesis in Azotobacter vinelandii nif
− mutants. J. 
Bacteriol., 169: 1784–1786 
13. Ugalde, R. A., J. Imperial, V.K. Shah and W.J. 
Brill, 1984. Biosynthesis of iron-molybdenum 
cofactor in the absence of nitrogenase. J. Bacteriol., 
159: 888–893. 
14. Shah, V.K., J. Imperial, R.A. Ugalde, Ludden, 
P.W. and W.J. Brill, 1986. In vitro synthesis of the 
iron-molybdenum cofactor of nitrogenase. Proc. 
Natl. Acad. Sci. USA, 83: 1636-1640. 
15.  Meijer, W.G. and F.R. Tabita, 1992. Isolation and 
characterization of the nifUSVW-rpoN gene cluster 
from Rhodobacter sphaeroides. J. Bacteriol., 174: 
3855-3866. Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
 
  101
16.  Paustian, T.D., V.K. Shah and G.P. Roberts, 1989. 
Purification and characterization of the nifN and 
nifE gene products from Azotobacter vinelandii 
mutant UW45. Proc. Natl. Acad. Sci. USA, 86: 
6082-6086. 
17. Robinson, A.C., D.R. Dean and B.K. Burgess, 
1987. Ironmolybdenum cofactor biosynthesis in 
Azotobacter vinelandii requires the iron protein of 
nitrogenase. J. Biol. Chem., 262:14327-14332 
18. Shah, V.K., J.R. Allen, N.J. Spangler and P.W. 
Ludden, 1994. In vitro synthesis of the iron-
molybdenum cofactor of nitrogenase. Purification 
and characterization of NifB cofactor, the product 
of NIFB protein. J. Biol. Chem., 269: 1154-1158. 
19.  Allen, R.M., R. Chatterjee, P.W. Ludden and V.K. 
Shah, 1995. Incorporation of iron and sulfur from 
NifB cofactor into the iron-molybdenum cofactor 
of dinitrogenase.  J. Biol. Chem., 270: 26890-
26896. 
20. Goodwin, P.J., J.N. Agar, J.T. Roll, G.P. Roberts, 
M.K. Johnson and D.R. Dean. The Azotobacter 
vinelandii  NifEN complex contains two identical 
[4Fe-4S] clusters. Biochemistry, 37: 10420-10428.  
21.  Roll, J.T., V.K. Shah, D.R. Dean and G.P. Roberts, 
1995. Characteristics of NIFNE in Azotobacter 
vinelandii strains. Implications for the synthesis of 
the iron-molybdenum cofactor of dinitrogenase. J. 
Biol. Chem., 270: 4432-4437. 
22.  Allen, R.M., R. Chatterjee, P.W. Ludden and V.K. 
Shah, 1996. The requirement of reductant for in 
vitro biosynthesis of the iron-molybdenum cofactor 
of nitrogenase. J. Biol. Chem., 271: 4256-4260. 
23. Chatterjee, R., R.M. Allen, V.K., Shah and P.W. 
Ludden, 1994. Nucleotide and divalent cation 
specificity of in vitro iron-molybdenum cofactor 
synthesis. J. Bacteriol., 176: 2747-2750. 
24. Homer, M.J., D.R. Dean and G.P. Roberts, 1995. 
Characterization of the γ protein and its 
involvement in the metallocluster assembly and 
maturation of dinitrogenase from Azotobacter 
vinelandii. J. Biol. Chem., 270: 24745-24752.  
25. Rubio, L.M., P. Rangaraj, M.J. Homer, G.P. 
Roberts and P.W. Ludden, 2002. Cloning and 
mutational analysis of the γ gene from Azotobacter 
vinelandii defines a new family of proteins capable 
of metallocluster binding and protein stabilization. 
J. Biol. Chem., 277: 14299-14305.  
26. Yuvaniyama, P., J.N. Agar, V.L. Cash, M.K. 
Johnson and D.R. Dean, 2000. NifS-directed 
assembly of a transient [2Fe-2S] cluster within the 
NifU protein. Proc. Natl. Acad. Sci. U.S.A., 97: 
599-604 
27. Zheng, L.M., R.H. White and D.R. Dean, 1997. 
Purification of the Azotobacter vinelandii nifV-
encoded homocitrate synthase. J. Bacteriol., 179: 
5963-5966.  
28. Imperial, J., R.A. Ugalde, V.K. Shah and W.J. 
Brill, 1984. Role of the nifQ gene product in the 
incorporation of molybdenum into nitrogenase in 
Klebsiella pneumoniae. J. Bacteriol., 158: 187-94 
29. Kennedy, C. and D.R. Dean, 1992. The nifU, nifS 
and nifV gene products are required for activity of 
all three nitrogenases of Azotobacter vinelandii. 
Mol. Gen. Genet., 231: 494-8.  
30. Rangaraj, P., C. Ruttimann-Johnson, V.K. Shah 
and P.W. Ludden, 2001. Accumulation of 
55Fe-
labeled precursors of the iron-molybdenum 
cofactor of nitrogenase on NifH and NifX of 
Azotobacter vinelandii. J. Biol. Chem., 276: 15968-
15974 
31.  Rangaraj, P. and P.W. Ludden, 2002. 
Accumulation of 
99Mo-containing Iron-
Molybdenum Cofactor Precursors of Nitrogenase 
on NifNE, NifH and NifX of Azotobacter 
vinelandii. J. Biol. Chem., 277: 40106-40111.  
32. http://ca.expasy.org/uniprot/P14887 
33. Anantharaman, V., E.V. Koonin and L. Aravind, 
2001. Regulatory potential, phyletic distribution 
and evolution of ancient, intracellular small-
molecule-binding domains. J. Mol. Biol., 307: 
1271-1292. 
34. Jacobson, M.R., K.E. Brigle, L.T. Bennett, R.A. 
Setterquist, M.S. Wilson, V.L. Cash, J. Beynon, 
W.E. Newton and D.R. Dean, 1989. Physical and 
genetic map of the major nif  gene cluster from 
Azotobacter vinelandii. J. Bacteriol., 171: 1017-27. 
35.  Dyer, D.H., L.M. Rubio, J.B. Thoden, H.M. 
Holden, P.W. Ludden and I. Rayment, 2003. The 
three-dimensional structure of the core domain of 
NafY from Azotobacter vinelandii determined at 
1.8-A resolution. 278: 32150-6. 
36. Dove, S.L., J.K. Joung and J.K.A. Hochschild, 
1997. Activation of prokaryotic transcription 
through arbitrary protein–protein contacts. Nature, 
386: 627–630. 
37.  BacterioMatch Two-Hybrid System Instruction 
Manual. 2001. Stratagene, Inc., La Jolla, CA. 
38.  Sambrook, J.F., E.F. Fritsch and T. Maniatis, 1992. 
Molecular Cloning: A Laboratory Manual, Cold 
Spring Harbor Laboratory, Cold Spring Harbor, 
New York. Am. J. Biochem. & Biotechnol., 3 (2): 96-106, 2007 
 
  102
39. Verma, S., 2002. Investigation of the NifM-NifH 
interaction using BacterioMatch Two Hybrid 
System. Masters thesis. Bowling Green State 
University, Biological Sciences Department. 
40.  Lahiri, S., L. Pulakat and N. Gavini, 2005. 
Functional NifD-K fusion protein in Azotobacter 
vinelandii is a homodimeric complex equivalent to 
the native heterotetrameric MoFe protein. 
Biochem. Biophys. Res. Commun., 337: 677-684 
41. Schwede, T., J. Kopp, N. Guex and M. Peitsch, 
2003. SWISS-MODEL: An automated protein 
homology-modeling server. Nucl. Acids Res., 31: 
3381-3385. 
42. Joerger, R.D. and P.E. Bishop, 1988. Nucleotide 
sequence and genetic analysis of the nifB-nifQ 
region from Azotobacter vinelandii. J. Bacteriol., 
170: 1475-1487. 
43. Marchler-Bauer, A. and S.H. Bryant, 2004. CD-
Search: protein domain annotations on the fly. 
Nucleic Acids Res., 32: 327-331. 
44. Curatti, L., P.W. Ludden and L.M. Rubio, 2006. 
NifB-dependent  in vitro synthesis of the iron–
molybdenum cofactor of nitrogenase. Proc. Natl. 
Acad. Sci. USA, 103: 5297–5301. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45. Suh, M-H., L. Pulakat and N. Gavini, 2003. 
Functional expression of a fusion-dimeric MoFe 
protein of nitrogenase in Azotobacter vinelandii. J. 
Biol. Chem., 278: 5353-60. 
46. Corbett, M.C., Y. Hu, A.W. Fay, M.W. Ribbe, B. 
Hedman and K.O. Hodgson, 2006. Structural 
insights into a protein-bound iron-molybdenum 
cofactor precursor. Proc. Natl. Acad. Sci. USA, 
103: 1238–1243. 
47.  Hu, Y., A.W. Fay and M.W. Ribbe, 2005. 
Identification of a nitrogenase FeMo cofactor 
precursor on NifEN complex. Proc. Natl. Acad. 
Sci. USA, 102: 3236–3241.  
48.  Ribbe, M.W. and B.K. Burgess, 2001. The 
chaperone GroEL is required for the final assembly 
of the molybdenum-iron protein of nitrogenase. 
Proc. Natl. Acad. Sci. USA, 98: 5521-5525.  
49. Homer, M.J., T.D. Paustian, V.K. Shah and G.P. 
Roberts, 1993. The nifY product of Klebsiella 
pneumoniae is associated with apodinitrogenase 
and dissociates upon activation with the iron-
molybdenum cofactor. J. Bacteriol., 175: 4907–
4910. 
 